Power Law company profile

Molbio Diagnostics

Health Tech & Medtech · Mormugao, India · Founded 2000 Unicorn

Enabling better medicine through precise, rapid, cost-effective molecular diagnosis at the Point of Care

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Revenue

$100–500M

Latest reported FY

Unlock exact value

Headcount

500–1k

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

2 investors on Molbio Diagnostics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage

Motilal Oswal Private Wealth Management

Temasek

Global footprint

Where Molbio Diagnostics has talent and traffic

Workforce by country

15 countries with
team presence

🇮🇳 India95.9%

🇬🇧 United Kingdom0.7%

🇪🇹 Ethiopia0.5%

🇳🇬 Nigeria0.5%

🇺🇸 United States0.3%

Top 5 of 15 shown

Web traffic by country

15K monthly visits
across markets

🇮🇳 India98%

🇺🇸 United States4.7%

Top 2 markets shown

Market sentiment

What the market is saying about Molbio Diagnostics

An AI-synthesized read of the highest-engagement posts about Molbio Diagnostics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Molbio Diagnostics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles